Phase I/II multicentre trial of salvage chemotherapywith Gem-TIP for relapsed germ cell cancer.

Trial Profile

Phase I/II multicentre trial of salvage chemotherapywith Gem-TIP for relapsed germ cell cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Gemcitabine (Primary) ; Chlorphenamine; Cisplatin; Dexamethasone; Filgrastim; Ifosfamide; Lenograstim; Mesna; Paclitaxel; Pegfilgrastim; Ranitidine
  • Indications Germ cell and embryonal neoplasms
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Jan 2013 Planned end date changed from 31 Aug 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
    • 03 Oct 2012 Accrual to date is 100% according to United Kingdom Clinical Research Network.
    • 03 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top